RCA
AGN

Rowland Carmichael Advisors’s Allergan plc AGN Stock Holding History

Rowland Carmichael Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,565
Closed -$928K – 370
2018
Q2 		$928K Sell
5,565
-25
-0.4% -$4.01K 0.39% 61
2018
Q1 		$941K Buy
5,590
+277
+5% +$46.5K 0.52% 60
2017
Q4 		$869K Sell
5,313
-93
-2% -$16.7K 0.45% 67
2017
Q3 		$1.11M Buy
5,406
+1,127
+26% +$262K 0.61% 35
2017
Q2 		$1.04M Hold
4,279
– – 0.6% 40
2017
Q1 		$1.02M Hold
4,279
– – 0.62% 36
2016
Q4 		$899K Hold
4,279
– – 0.53% 62
2016
Q3 		$985K Sell
4,279
-25
-0.6% -$6.11K 0.63% 50
2016
Q2 		$995K Buy
+4,304
New +$992K 0.63% 47

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Rowland Carmichael Advisors's AGN Position: Q3 2018 in Review

Rowland Carmichael Advisors sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 5,565 shares — an estimated $928K sold.

Rowland Carmichael Advisors first reported a position in AGN in Q2 2016 and held it in 9 quarters. The position peaked at $1.11M in Q3 2017. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • Rowland Carmichael Advisors reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • Rowland Carmichael Advisors sold 5,565 Allergan plc shares in Q3 2018, an estimated $928K.
  • Rowland Carmichael Advisors first reported a position in Allergan plc in Q2 2016 and held it in 9 quarters.
  • Rowland Carmichael Advisors's Allergan plc position peaked at $1.11M in Q3 2017.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on Rowland Carmichael Advisors's 13F filing for Q3 2018, filed 10 Feb 2020.